Sale!

Curbside Consultation of the Liver 49 Clinical Questions 1st Edition by Mitchell Shiffman ISBN 1556428154 9781556428159

Original price was: $50.00.Current price is: $35.00.

Curbside Consultation of the Liver 49 Clinical Questions 1st Edition Mitchell Shiffman Md Digital Instant Download

Author(s): Mitchell Shiffman MD
ISBN(s): 9781556428159, 1556428154
Edition: 1st
File Details: PDF, 5.80 MB
Year: 2008
Language: english
SKU: EB-4650080 Category: Tag:

Curbside Consultation of the Liver 49 Clinical Questions 1st Edition by Mitchell Shiffman – Ebook PDF Instant Download/Delivery: 1556428154, 9781556428159
Full download Curbside Consultation of the Liver 49 Clinical Questions 1st Edition after payment

Product details:

ISBN 10: 1556428154 
ISBN 13: 9781556428159
Author: Mitchell Shiffman

Are you looking for concise, practical answers to questions that are often left unanswered by traditional liver references? Are you seeking brief, evidence-based advice for complicated cases or complications? Curbside Consultation of the Liver: 49 Clinical Questions provides quick and direct answers to the thorny questions commonly posed during a “curbside consultation” between colleagues. Dr. Mitchell Shiffman has designed this unique reference, which offers expert advice, preferences, and opinions on tough clinical questions commonly associated with the liver. The unique Q&A format provides quick access to current information related to the liver with the simplicity of a conversation between two colleagues. Numerous images, diagrams, and references are included to enhance the text and to illustrate the treatment of the liver. Curbside Consultation of the Liver: 49 Clinical Questions provides information basic enough for residents while also incorporating expert advice that even high-volume clinicians will appreciate. Gastroenterologists, fellows, residents in training, and medical students will benefit from the user-friendly and casual format and the expert advice contained within. Some of the questions that are answered: How often should I follow a patient who had chronic hepatitis C after they achieved a sustained virologic response? Should I stop the HIV medications in a patient who has developed an elevation in serum liver transaminases? What should I tell my patient who is a carrier for alpha-1-antitrypsin deficiency? Which patients with fatty liver disease on an ultrasound examination require a liver biopsy? Which patients with chronic liver disease should I screen for hepatocellular carcinoma? How much ascites is safe to remove at any time?

Curbside Consultation of the Liver 49 Clinical Questions 1st Table of contents:

Section I: Viral Hepatitis C

  1. What is the likelihood that my patient with chronic hepatitis C will develop cirrhosis, hepatocellular carcinoma, and/or hepatic decompensation?

  2. How should a patient who tests positive for chronic hepatitis C but has persistently normal serum aminotransaminases (PNAT) be evaluated?

  3. Do all patients with chronic hepatitis C virus require a liver biopsy?

  4. How often should I measure chronic hepatitis C RNA while treating with peginterferon and ribavirin?

  5. Anemia during peginterferon/ribavirin therapy: reduce ribavirin or use epoetin alfa?

  6. Improving treatment response in African American patients with chronic hepatitis C

  7. Is it safe to treat chronic hepatitis C and cirrhosis with peginterferon and ribavirin?

  8. Post-SVR follow-up: how often?

Section II: Viral Hepatitis B

  1. Which patients with chronic hepatitis B require a liver biopsy?

  2. Choosing medications for hepatitis B: E-antigen positive and negative patients

  3. Can treatment with oral antivirals be stopped?

  4. How to recognize and manage antiviral resistance in HBV treatment

  5. Treating patients co-infected with hepatitis B and C

Section III: Liver Disease in Patients with HIV Infection

  1. Impact of HIV on cirrhosis risk in chronic hepatitis C

  2. Who should be treated for HCV-HIV coinfection?

  3. How to treat HBV-HIV coinfection simply

  4. Causes of jaundice in HIV-infected patients

  5. Elevated liver enzymes during HIV therapy: should medications be stopped?

Section IV: Genetic Disorders That Cause Chronic Liver Disease

  1. Best screening test for genetic hemochromatosis

  2. Phlebotomy frequency in genetic hemochromatosis

  3. Best screening test for Wilson’s disease

  4. Counseling carriers of alpha-1-antitrypsin deficiency

  5. Does every autoimmune hepatitis patient need immunosuppression?

  6. Alternatives to corticosteroids for autoimmune hepatitis

  7. Is liver biopsy necessary before steroid treatment in autoimmune hepatitis?

Section V: Fatty Liver Disease

  1. Who needs liver biopsy with fatty liver seen on ultrasound?

  2. Statins and elevated liver enzymes — stop or continue?

  3. Best treatment for fatty liver with type 2 diabetes mellitus

  4. HCV with coexisting NASH — how to improve treatment response

  5. Can non-obese, non-diabetic, normal-cholesterol patients have fatty liver disease?

Section VI: Cholestatic Liver Disease

  1. When and how to initiate ursodeoxycholic acid for PBC?

  2. What testing is needed for PBC?

  3. Is ursodeoxycholic acid effective for PSC?

  4. Should PSC patients be screened for cholangiocarcinoma?

  5. Role of ERCP in diagnosing PSC

  6. Does colectomy reduce PSC risk in ulcerative colitis patients?

Section VII: Cirrhosis

  1. When to screen asymptomatic cirrhosis patients for esophageal varices?

  2. Post-variceal banding — what next?

  3. Who should be screened for hepatocellular carcinoma?

  4. Should cirrhosis patients be vaccinated for Hep A and B?

  5. Incidental 4 cm liver mass — should it be biopsied?

  6. How much ascitic fluid is safe to remove?

  7. Elevated creatinine with persistent ascites on diuretics — next step?

  8. Duration of antibiotic therapy for SBP

  9. Elevated ammonia without encephalopathy — lactulose recommendation?

  10. Persistent encephalopathy despite lactulose — increase the dose?

Section VIII: Liver Transplantation

  1. Should a fatigued but stable cirrhosis patient be referred for transplant?

  2. Management of a new 2-cm liver mass in cirrhosis

  3. Long-term liver transplant follow-up with rising creatinine — now what?

People also search for Curbside Consultation of the Liver 49 Clinical Questions 1st:

curbsiders liver
    
curbsiders liver function tests
    
curbsiders liver tests
    
liver cirrhosis curbsiders
    
curbsiders acute liver failure

Tags: Mitchell Shiffman, Curbside Consultation, Clinical Questions